Gamma-aminobutyric acid type A receptor subunit alpha (GABRA) (GABRA)

The Gamma-aminobutyric acid type A receptor subunit alpha (GABRA) family consists of six isoforms (alpha 1-6) that are integral components of the GABA-A receptor, the primary inhibitory neurotransmitter receptor in the central nervous system (UniProt, 2023). These subunits assemble with beta and gamma subunits to form a pentameric chloride channel; the specific alpha isoform present significantly influences the receptor's physiological properties and pharmacological profile (IUPHAR/BPS, 2024). Activation of these receptors by the neurotransmitter GABA leads to chloride influx and neuronal hyperpolarization, which is essential for regulating brain excitability and preventing over-excitation (Sigel & Steinmann, 2012, PMID: 23126454). The alpha subunits are the primary targets for several classes of drugs, most notably benzodiazepines, which bind at the alpha-gamma interface to enhance GABA's inhibitory effects (Olsen & Sieghart, 2008, PMID: 18394311). Dysfunctional GABRA signaling is implicated in a variety of CNS disorders, including epilepsy, anxiety, and insomnia, making these subunits high-value targets for therapeutic intervention. Current drug development efforts often aim for subunit-selective modulation to minimize side effects like sedation and ataxia while maintaining therapeutic efficacy for specific indications like pain or cognitive impairment (PubMed, PMID: 22303013).

Other names

GABA(A) receptor subunit alphaGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6Gamma-aminobutyric acid receptor subunit alpha

Positive allosteric modulation of the GABA-A receptor complex, which increases the frequency or duration of chloride channel opening in response to GABA binding (StatPearls, 2023; IUPHAR/BPS, 2024).